Michele Pezzella

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression

R. Taulli, P. Mariottini, R. Maestro, 2022, Frontiers in Oncology.

FAK Signaling in Rhabdomyosarcoma

F. Locatelli, R. Rota, Silvia Pomella, 2020, International journal of molecular sciences.

Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.

D. Trisciuoglio, A. Mai, S. Minucci, 2022, European journal of medicinal chemistry.

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

M. Serafini, M. Riminucci, P. Merli, 2022, Journal of Hematology & Oncology.

Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation

P. Mariottini, A. Alisi, M. Cervelli, 2023, Frontiers in cell and developmental biology.

Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies

A. Mastronuzzi, Sofia Reddel, P. Merli, 2023, Nature Communications.

MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting

M. Yohe, B. Gryder, Z. Walters, 2023, Nature communications.